OCUL insider trading
Open-market stock trades by Ocular Therapeutix (OCUL) executives and directors: who bought or sold, how many shares, at what price and when.
OCUL insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | Sell | 11,984 | $7.29 | $87.36K |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | Sell | 9,990 | $7.05 | $70.43K |
| Oct 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,869 | $7.05 | $76.63K |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | Sell | 1,099 | $10.24 | $11.25K |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | Sell | 3,035 | $10.77 | $32.69K |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,897 | $10.78 | $20.45K |
| Aug 24, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,296 | $10.78 | $35.53K |
| Aug 24, 2026 | Dugel Pravin | See Remarks | Sell | 21,649 | $10.77 | $233.16K |
| Jun 3, 2026 | Waheed Nadia | Chief Medical Officer | Sell | 14,828 | $8.27 | $122.63K |
| May 26, 2026 | Dugel Pravin | See Remarks | Sell | 21,156 | $8.20 | $173.48K |
| May 26, 2026 | Kaiser Peter | Chief Development Officer | Sell | 2,967 | $8.20 | $24.33K |
| May 26, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,018 | $8.20 | $24.75K |
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,858 | $8.20 | $15.24K |
| Feb 23, 2026 | Dugel Pravin | See Remarks | Sell | 20,056 | $8.28 | $166.06K |
| Feb 23, 2026 | Kaiser Peter | Chief Development Officer | Sell | 2,810 | $8.28 | $23.27K |
| Feb 23, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,057 | $8.28 | $25.31K |
| Feb 23, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,759 | $8.28 | $14.56K |
| Feb 20, 2026 | Waheed Nadia | Chief Medical Officer | Sell | 3,510 | $7.74 | $27.17K |
| Feb 20, 2026 | LINDSTROM RICHARD L MD | director | Buy | 60,229 | $7.66 | $461.35K |
| Feb 12, 2026 | Notman Donald | Chief Operating Officer | Sell | 11,446 | $9.04 | $103.47K |
| Feb 12, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 10,348 | $9.04 | $93.55K |
| Feb 12, 2026 | Dugel Pravin | See Remarks | Sell | 124,882 | $9.04 | $1.13M |
| Feb 12, 2026 | Waheed Nadia | Chief Medical Officer | Sell | 7,863 | $9.04 | $71.08K |
| Feb 2, 2026 | Notman Donald | Chief Operating Officer | Sell | 5,455 | $9.14 | $49.86K |
| Feb 4, 2026 | Notman Donald | Chief Operating Officer | Sell | 6,035 | $8.54 | $51.54K |
| Nov 24, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,878 | $12.04 | $22.61K |
| Nov 24, 2025 | Dugel Pravin | See Remarks | Sell | 19,530 | $12.04 | $235.14K |
| Nov 24, 2025 | Kaiser Peter | Chief Development Officer | Sell | 3,007 | $12.02 | $36.14K |
| Nov 24, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,469 | $12.04 | $41.77K |
| Nov 5, 2025 | Saroj Namrata | Chief Business Officer | Sell | 25,865 | $10.74 | $277.79K |
| Oct 8, 2025 | Anderman Todd | Chief Legal Officer | Sell | 11,132 | $12.34 | $137.37K |
| Oct 2, 2025 | Kaiser Peter | Chief Development Officer | Sell | 9,653 | $11.03 | $106.47K |
| Oct 2, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,502 | $11.04 | $115.94K |
| Sep 2, 2025 | Notman Donald | See Remarks | Sell | 1,066 | $12.43 | $13.25K |
| Aug 25, 2025 | Kaiser Peter | Chief Development Officer | Sell | 3,011 | $12.04 | $36.25K |
| Aug 25, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,885 | $12.04 | $22.70K |
| Aug 25, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,063 | $12.04 | $36.88K |
| Aug 25, 2025 | Dugel Pravin | See Remarks | Sell | 21,494 | $12.04 | $258.79K |
- OCUL insiders bought $461.35K and sold $4.02M in open-market trades over their last 38 filings.
Updated 2026-11-03 12:34 UTC